Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    - Revision updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:49:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:38:50.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-status notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T05:55:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a government funding-status notice and a site update to Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T05:45:17.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Glossary display was added to the study page, along with a new label 'Last Update Submitted that Met QC Criteria' and a site revision tag 'Revision: v3.4.0'. The prior label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' entry, and the older revision tag 'Revision: v3.3.4' were removed.
    Difference
    0.3%
    Check dated 2026-01-28T04:11:54.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:34:10.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.